A few nonspecific comments about acquisitions by CEO and Chairman of Johnson & Johnson Alex Gorsky, boosted TransEnterix's stock.
Here are five things to know:
1. TransEnterix's stock went up by nearly 30 percent.
2. TransEnterix could possible be one of the rumored acquisitions with Johnson & Johnson.
3. During a conference call to discuss fourth quarter results, Mr. Gorsky talked at different times about potential acquisitions, specifically in medical devices.
4. TransEnterix develops and markets surgical robots.
5. This comes in light of Johnson & Johnson's recent news that it will cut about 6 percent of its medical device jobs.